Abstract
Classical Susceptible-Infected-Removed model with constant transmission rate and removal rate may not capture real world dynamics of epidemic due to complex influence of multiple external factors on the spread. On top of that transmission rate may vary widely in a large region due to non-stationarity of spatial features which poses difficulty in creating a global model. We modified discrete global Susceptible-Infected-Removed model by using time varying transmission rate, recovery rate and multiple spatially local models. No specific functional form of transmission rate has been assumed. We have derived the criteria for disease-free equilibrium within a specific time period. A single Convolutional LSTM model is created and trained to map multiple spatiotemporal features to transmission rate. The model achieved 8.39% mean absolute percent error in terms of cumulative infection cases in each locality in a 10-day prediction period. Local interpretations of the model using perturbation method reveals local influence of different features on transmission rate which in turn is used to generate a set of generalized global interpretations. A what-if scenario with modified recovery rate illustrates rapid dampening of the spread when forecasted with the trained model. A comparative study with current normal scenario reveals key necessary steps to reach baseline.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Not applicable
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail: saikat.jana{at}tcs.com.
E-mail: parama.bhumik{at}jusl.ac.in.
Data Availability
Data is available publicly and cited in the article
